MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy

Methotrexate (MTX) is an important component in the therapy used to treat childhood acute lymphoblastic leukemia (ALL). Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme for MTX pharmacokinetics. Two single-nucleotide polymorphisms in MTHFR gene, C677T and A1298C, affecting MTHFR activity,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pharmgenomics Pers Med
Glavni autori: Umerez, Maitane, Gutierrez-Camino, Ángela, Muñoz-Maldonado, Carmen, Martin-Guerrero, Idoia, Garcia-Orad, Africa
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2017
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5376125/
https://ncbi.nlm.nih.gov/pubmed/28392709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S107047
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items